Literature DB >> 24898661

A cell model for the initial phase of sporadic Alzheimer's disease.

Carola Stockburger1, Vicki A M Gold2, Thea Pallas1, Natalie Kolesova1, Davide Miano1, Kristina Leuner3, Walter E Müller1.   

Abstract

Recent data suggest that the combined effect of oxidative stress due to aging and slightly elevated amyloid-β (Aβ) levels initiate Alzheimer's disease (AD) long before the clinical onset. Investigations of this early phase are hampered by the lack of cellular or animal models reflecting this scenario. We used SH-SY5Y cells stably transfected with an additional copy of the human AβPP gene and artificial aging by complex I inhibition. These cells show slightly elevated Aβ levels, moderately decreased ATP levels, impaired mitochondrial membrane potential, and decreased mitochondrial respiration. Assessing mitochondrial dynamics with three different methods reveals a distinct shift toward mitochondrial fission and fragmentation in SH-SY5Y AβPPwt cells. We also performed electron cryo-tomography of isolated mitochondria to reveal that there were no major differences between SH-SY5Y control and SH-SY5Y AβPPwt mitochondria with respect to swelling or loss of cristae. Dystrophic neurites are an early pathological feature of AD. Interestingly, SH-SY5Y AβPPwt cells exhibit significantly longer neurites, likely due to substantially elevated levels of sAβPPα. Complex I inhibition also shows substantial effects on mitochondrial dynamics, impairs neuritogenesis, and elevates Aβ levels in both cell types. In SH-SY5Y AβPPwt cells, these defects were more pronounced due to a relatively elevated Aβ and a reduced sAβPPα production. Our findings suggest that the progression from low Aβ levels to the beginning of AD takes place in the presence of oxidative stress during normal aging. This mechanism not only results from additive effects of both mechanisms on mitochondrial function but might also be additionally aggravated by altered amyloidogenic processing.

Entities:  

Keywords:  Aging; Alzheimer's disease; amyloid-β; mitochondrial dynamics; mitochondrial function

Mesh:

Substances:

Year:  2014        PMID: 24898661     DOI: 10.3233/JAD-140381

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

Review 1.  Melatonin as a mitochondrial protector in neurodegenerative diseases.

Authors:  Pawaris Wongprayoon; Piyarat Govitrapong
Journal:  Cell Mol Life Sci       Date:  2017-08-08       Impact factor: 9.261

2.  Walnut Oil Reduces Aβ Levels and Increases Neurite Length in a Cellular Model of Early Alzheimer Disease.

Authors:  Carsten Esselun; Fabian Dieter; Nadine Sus; Jan Frank; Gunter P Eckert
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

3.  Genistein, the Isoflavone in Soybean, Causes Amyloid Beta Peptide Accumulation in Human Neuroblastoma Cell Line: Implications in Alzheimer's Disease.

Authors:  Gargi Chatterjee; Debashree Roy; Vineet Kumar Khemka; Mrittika Chattopadhyay; Sasanka Chakrabarti
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

4.  Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue.

Authors:  Lilli Winter; Ilka Wittig; Viktoriya Peeva; Britta Eggers; Juliana Heidler; Frederic Chevessier; Rudolf A Kley; Katalin Barkovits; Valentina Strecker; Carolin Berwanger; Harald Herrmann; Katrin Marcus; Cornelia Kornblum; Wolfram S Kunz; Rolf Schröder; Christoph S Clemen
Journal:  Acta Neuropathol       Date:  2016-07-08       Impact factor: 17.088

5.  Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function.

Authors:  Carola Stockburger; Davide Miano; Thea Pallas; Kristina Friedland; Walter E Müller
Journal:  Neural Plast       Date:  2016-09-26       Impact factor: 3.599

Review 6.  Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer's Disease.

Authors:  Schamim H Eckert; Janett Gaca; Nathalie Kolesova; Kristina Friedland; Gunter P Eckert; Walter E Muller
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

7.  Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells.

Authors:  Fabian Dieter; Carsten Esselun; Gunter P Eckert
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

8.  Local Oxidative Damage in the Soma and Dendrites Quarantines Neuronal Mitochondria at the Site of Insult.

Authors:  Amandine Grimm; Nadia Cummins; Jürgen Götz
Journal:  iScience       Date:  2018-07-23

9.  Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease.

Authors:  Lukas Babylon; Rekha Grewal; Pascal-L Stahr; Ralph W Eckert; Cornelia M Keck; Gunter P Eckert
Journal:  Antioxidants (Basel)       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.